HF
BRTX icon

HRT Financial’s BioRestorative Therapies BRTX Stock Holding History

HRT Financial’s Portfolio BRTX Stock Details BRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$267K Buy
+710,590
New +$208K ﹤0.01% 3174
2024
Q1 		– Sell
-12,485
Closed -$21K – 2366
2023
Q4 		$21K Buy
+12,485
New +$23.8K ﹤0.01% 2035

Other funds holding BRTX

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
WA
Wealth Alliance Mellville, New York $1.2B AUM 26.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KFGK
Keystone Financial Group (Kentucky) Lexington, Kentucky $1.69B AUM 40.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

HRT Financial's BRTX Position: Q2 2026 in Review

HRT Financial opened a new position in BioRestorative Therapies (BRTX) in Q2 2026: 710,590 shares worth $267K. The stake represents ﹤0.01% of the portfolio and ranks #3174 among its holdings. This is a return to the name: HRT Financial previously reported a position in BRTX as recently as Q4 2023.

HRT Financial first reported a position in BRTX in Q4 2023 and has held it in 2 quarters since. 21 funds tracked by Wall St. Rank hold BRTX as of Q2 2026.

  • HRT Financial held 710,590 shares of BioRestorative Therapies worth $267K as of Q2 2026.
  • BioRestorative Therapies was a new HRT Financial position in Q2 2026.
  • BioRestorative Therapies made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3174 holding.
  • HRT Financial first reported a position in BioRestorative Therapies in Q4 2023 and has held it in 2 quarters since.
  • 21 funds tracked by Wall St. Rank held BioRestorative Therapies as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.